Benjamin H. Mullish

7.3k total citations · 2 hit papers
135 papers, 3.8k citations indexed

About

Benjamin H. Mullish is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Benjamin H. Mullish has authored 135 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 66 papers in Infectious Diseases and 57 papers in Epidemiology. Recurrent topics in Benjamin H. Mullish's work include Gut microbiota and health (71 papers), Clostridium difficile and Clostridium perfringens research (65 papers) and Liver Disease Diagnosis and Treatment (30 papers). Benjamin H. Mullish is often cited by papers focused on Gut microbiota and health (71 papers), Clostridium difficile and Clostridium perfringens research (65 papers) and Liver Disease Diagnosis and Treatment (30 papers). Benjamin H. Mullish collaborates with scholars based in United Kingdom, United States and Italy. Benjamin H. Mullish's co-authors include Julian R. Marchesi, Jessica R. Allegretti, Horace R. Williams, Mark Thursz, Julie A. K. McDonald, Monika Fischer, Colleen Kelly, Jonathan Segal, Zain Kassam and Elaine Holmes and has published in prestigious journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Benjamin H. Mullish

123 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

2018 251 citations Benjamin H. Mullish, Ailsa Hart et al. profile →
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications

2019 250 citations Jessica R. Allegretti, Benjamin H. Mullish et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin H. Mullish United Kingdom	33	2.2k	1.7k	1.1k	701	673	135	3.8k
Mohammed Nabil Quraishi United Kingdom	19	2.0k 0.9×	1.1k 0.6×	676 0.6×	534 0.8×	504 0.7×	63	3.3k
Kathleen Machiels Belgium	25	3.2k 1.4×	1.1k 0.7×	1.0k 0.9×	671 1.0×	711 1.1×	60	4.7k
Monika Fischer United States	30	1.3k 0.6×	1.8k 1.1×	1.9k 1.6×	850 1.2×	901 1.3×	142	3.8k
Zain Kassam United States	31	3.1k 1.4×	3.4k 2.0×	2.2k 1.9×	1.7k 2.4×	1.1k 1.7×	135	5.4k
Bangmao Wang China	30	2.0k 0.9×	338 0.2×	549 0.5×	470 0.7×	707 1.1×	149	3.5k
Marius Trøseid Norway	32	1.9k 0.8×	856 0.5×	926 0.8×	200 0.3×	470 0.7×	126	3.9k
Arnau Vich Vila Netherlands	27	3.6k 1.6×	906 0.5×	752 0.7×	721 1.0×	768 1.1×	47	5.4k
Floris Imhann Netherlands	16	2.5k 1.1×	709 0.4×	611 0.5×	610 0.9×	661 1.0×	23	3.9k
Johannes R. Hov Norway	36	1.8k 0.8×	513 0.3×	1.2k 1.1×	359 0.5×	1.1k 1.6×	118	4.2k
Rodrigo Quera Chile	22	2.3k 1.1×	536 0.3×	689 0.6×	521 0.7×	887 1.3×	147	4.6k

Countries citing papers authored by Benjamin H. Mullish

Since Specialization

Citations

This map shows the geographic impact of Benjamin H. Mullish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin H. Mullish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin H. Mullish more than expected).

Fields of papers citing papers by Benjamin H. Mullish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin H. Mullish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin H. Mullish. The network helps show where Benjamin H. Mullish may publish in the future.

Co-authorship network of co-authors of Benjamin H. Mullish

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin H. Mullish. A scholar is included among the top collaborators of Benjamin H. Mullish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin H. Mullish. Benjamin H. Mullish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yip, Alexander, Jesús Miguéns Blanco, Julian R. Marchesi, et al.. (2025). Vancomycin-resistant enterococci utilise antibiotic-enriched nutrients for intestinal colonisation. Nature Communications. 16(1). 6376–6376.

Mullish, Benjamin H., Márton Ölbei, Nathan Danckert, et al.. (2025). Deciphering the microbiome–metabolome landscape of an inflammatory bowel disease inception cohort. Gut Microbes. 17(1). 2527863–2527863. 2 indexed citations

Qureshi, Kristine, L. Roberts, Nick Powell, et al.. (2025). The emerging role of the gut microbiota in vaccination responses. Gut Microbes. 17(1). 2549585–2549585.

Nilsson, Anna Christine, Muhammad Malik, Heidi Lausten Munk, et al.. (2024). Dynamics of inflammation-associated plasma proteins following faecal microbiota transplantation in patients with psoriatic arthritis and healthy controls: exploratory findings from the FLORA trial. RMD Open. 10(1). e003750–e003750. 9 indexed citations

Mullish, Benjamin H., Andrew J. Innes, Lauren A. Roberts, et al.. (2024). Intestinal M icrobiota Transplant Prior to A llogeneic S tem Cell T ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial. BMJ Open. 14(12). e093120–e093120. 1 indexed citations

Balarajah, Sharmili, Laura Martínez-Gili, James L. Alexander, et al.. (2024). OP07 Consistent IBD treatment approaches across South Asian and White ethnicities despite phenotypic variations: a study of 33,157 patients using the IBD BioResource. Journal of Crohn s and Colitis. 18(Supplement_1). i13–i13. 1 indexed citations

Mullish, Benjamin H. & Mark Thursz. (2024). Alcohol-associated liver disease: Emerging therapeutic strategies. Hepatology. 80(6). 1372–1389. 3 indexed citations

Perry, Robert, Benjamin H. Mullish, James L. Alexander, et al.. (2024). 3D printed rectal swabs for assessing the gut microbiome, metabolome and inflammation. Scientific Reports. 14(1). 16613–16613. 1 indexed citations

Forlano, Roberta, Sahan Jayawardana, Benjamin H. Mullish, et al.. (2023). A prospective study on the prevalence of MASLD in people with type‐2 diabetes in the community. Cost effectiveness of screening strategies. Liver International. 44(1). 61–71. 23 indexed citations

10.

Yip, Alexander, Nathan Danckert, Rohma Ghani, et al.. (2023). Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites. Nature Communications. 14(1). 5094–5094. 45 indexed citations

11.

Severino, Andrea, Serena Porcari, William G. Fusco, et al.. (2023). Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy. Antibiotics. 12(5). 868–868. 28 indexed citations

12.

Huang, Jian, Benjamin H. Mullish, Dan Wang, et al.. (2023). Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective. Nutrients. 15(8). 1992–1992. 6 indexed citations

13.

Churchward, Matthew A., Benjamin H. Mullish, Jesús Miguéns Blanco, et al.. (2023). Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation. Heliyon. 9(6). e16908–e16908. 9 indexed citations

14.

Forlano, Roberta, Benjamin H. Mullish, Michael Yee, et al.. (2023). Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 24(4). 3563–3563. 3 indexed citations

15.

Mullish, Benjamin H., Laura Martínez-Gili, Elena Chekmeneva, et al.. (2022). Assessing the clinical value of faecal bile acid profiling to predict recurrence in primary Clostridioides difficile infection. Alimentary Pharmacology & Therapeutics. 56(11-12). 1556–1569. 6 indexed citations

16.

Alexander, James L., Benjamin H. Mullish, Kate Gallagher, et al.. (2021). Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 55(1). 26–48. 33 indexed citations

17.

Forlano, Roberta, Christopher Harlow, Benjamin H. Mullish, et al.. (2021). Binge‐eating disorder is associated with an unfavorable body mass composition in patients with non‐alcoholic fatty liver disease. International Journal of Eating Disorders. 54(11). 2025–2030. 7 indexed citations

18.

Forlano, Roberta, Benjamin H. Mullish, Νικόλαος Γιαννακέας, et al.. (2019). High-Throughput, Machine Learning–Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 18(9). 2081–2090.e9. 96 indexed citations

19.

Abeles, R.D., Benjamin H. Mullish, Roberta Forlano, et al.. (2019). Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non‐alcoholic fatty liver disease; the importance of an elevated mean platelet volume. Alimentary Pharmacology & Therapeutics. 49(8). 1077–1085. 30 indexed citations

20.

Forlano, Roberta, et al.. (2017). Assessment of non invasive markers of fibrosis against collagen quantitation and NASH-CRN scoring in liver biopsies of NAFLD patients. Spiral (Imperial College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact